nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—ALOX5—Synthesis of 5-eicosatetraenoic acids—GPX1—dilated cardiomyopathy	0.0487	0.0602	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—DSP—dilated cardiomyopathy	0.0394	0.0487	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—NPPB—dilated cardiomyopathy	0.0367	0.0454	CbGpPWpGaD
Masoprocol—IGF1R—Stabilization and expansion of the E-cadherin adherens junction—VCL—dilated cardiomyopathy	0.0357	0.0441	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—VCL—dilated cardiomyopathy	0.0258	0.0319	CbGpPWpGaD
Masoprocol—LTB4R—heart—dilated cardiomyopathy	0.023	0.202	CbGeAlD
Masoprocol—IGF1R—IGF1 pathway—RPS6KB1—dilated cardiomyopathy	0.0209	0.0258	CbGpPWpGaD
Masoprocol—CYP2J2—cardiac ventricle—dilated cardiomyopathy	0.0196	0.172	CbGeAlD
Masoprocol—IGF1R—heart—dilated cardiomyopathy	0.019	0.166	CbGeAlD
Masoprocol—CYP2J2—myocardium—dilated cardiomyopathy	0.0184	0.162	CbGeAlD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—NPPA—dilated cardiomyopathy	0.017	0.021	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0167	0.0206	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—LAMA4—dilated cardiomyopathy	0.0166	0.0205	CbGpPWpGaD
Masoprocol—IGF1R—SHC-related events triggered by IGF1R—RAF1—dilated cardiomyopathy	0.0145	0.0179	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.0131	0.0162	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—RAC1—dilated cardiomyopathy	0.013	0.016	CbGpPWpGaD
Masoprocol—CYP2J2—heart—dilated cardiomyopathy	0.0129	0.113	CbGeAlD
Masoprocol—IGF1R—IGF1 pathway—RAF1—dilated cardiomyopathy	0.0125	0.0155	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—RPS6KB1—dilated cardiomyopathy	0.0115	0.0143	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—RPS6KB1—dilated cardiomyopathy	0.0111	0.0137	CbGpPWpGaD
Masoprocol—CYP2J2—cardiac atrium—dilated cardiomyopathy	0.011	0.0965	CbGeAlD
Masoprocol—Fenoterol—ADRB1—dilated cardiomyopathy	0.0108	0.141	CrCbGaD
Masoprocol—IGF1R—Focal Adhesion—VCL—dilated cardiomyopathy	0.0107	0.0132	CbGpPWpGaD
Masoprocol—IGF1R—Integrins in angiogenesis—RAC1—dilated cardiomyopathy	0.0104	0.0129	CbGpPWpGaD
Masoprocol—ALOX5—heart—dilated cardiomyopathy	0.0101	0.0889	CbGeAlD
Masoprocol—Arbutamine—ADRB1—dilated cardiomyopathy	0.0101	0.132	CrCbGaD
Masoprocol—CYP2J2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.01	0.0124	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.00974	0.012	CbGpPWpGaD
Masoprocol—Dobutamine—ADRB1—dilated cardiomyopathy	0.00933	0.122	CrCbGaD
Masoprocol—Fenoterol—ADRB2—dilated cardiomyopathy	0.00912	0.119	CrCbGaD
Masoprocol—ALOX5—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00894	0.011	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—FASLG—dilated cardiomyopathy	0.00876	0.0108	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—RPS6KB1—dilated cardiomyopathy	0.00875	0.0108	CbGpPWpGaD
Masoprocol—Arbutamine—ADRB2—dilated cardiomyopathy	0.00853	0.111	CrCbGaD
Masoprocol—IGF1R—IGF1R signaling cascade—RPS6KB1—dilated cardiomyopathy	0.00852	0.0105	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—FAS—dilated cardiomyopathy	0.00844	0.0104	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—RAC1—dilated cardiomyopathy	0.00828	0.0102	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—AGT—dilated cardiomyopathy	0.00791	0.00978	CbGpPWpGaD
Masoprocol—Dobutamine—ADRB2—dilated cardiomyopathy	0.00785	0.102	CrCbGaD
Masoprocol—CYP19A1—FSH signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00766	0.00946	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.00742	0.00917	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—RAF1—dilated cardiomyopathy	0.00738	0.00912	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00701	0.00866	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00697	0.00861	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—RAF1—dilated cardiomyopathy	0.00666	0.00823	CbGpPWpGaD
Masoprocol—Dopamine—SLC22A5—dilated cardiomyopathy	0.0066	0.0861	CrCbGaD
Masoprocol—IGF1R—Stabilization and expansion of the E-cadherin adherens junction—EGFR—dilated cardiomyopathy	0.00655	0.0081	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00651	0.00805	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00631	0.0078	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00623	0.0077	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.0062	0.00767	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.006	0.00742	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.006	0.00742	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00596	0.00737	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—dilated cardiomyopathy	0.00589	0.00728	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00583	0.00721	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00569	0.00703	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—RAF1—dilated cardiomyopathy	0.0056	0.00692	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00558	0.0069	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00553	0.00683	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—RAF1—dilated cardiomyopathy	0.00549	0.00678	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—RPS6KB1—dilated cardiomyopathy	0.00547	0.00676	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0054	0.00668	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00539	0.00666	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—ITGB1—dilated cardiomyopathy	0.00536	0.00662	CbGpPWpGaD
Masoprocol—Isoprenaline—ADRB1—dilated cardiomyopathy	0.00529	0.069	CrCbGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—RAF1—dilated cardiomyopathy	0.00524	0.00648	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.0052	0.00643	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00511	0.00632	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—RAF1—dilated cardiomyopathy	0.0051	0.00631	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—EGFR—dilated cardiomyopathy	0.00506	0.00626	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—RAC1—dilated cardiomyopathy	0.00494	0.00611	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.0049	0.00606	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00462	0.0057	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—RAF1—dilated cardiomyopathy	0.00459	0.00567	CbGpPWpGaD
Masoprocol—CYP19A1—FSH signaling pathway—RAF1—dilated cardiomyopathy	0.00459	0.00567	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00457	0.00565	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00457	0.00565	CbGpPWpGaD
Masoprocol—Dopamine—ADRB1—dilated cardiomyopathy	0.00456	0.0594	CrCbGaD
Masoprocol—Isoprenaline—ADRB2—dilated cardiomyopathy	0.00445	0.0581	CrCbGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00439	0.00542	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00438	0.00541	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—RAC1—dilated cardiomyopathy	0.00431	0.00533	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00425	0.00525	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00412	0.00509	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—EGFR—dilated cardiomyopathy	0.00384	0.00474	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—TNF—dilated cardiomyopathy	0.00359	0.00443	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TNF—dilated cardiomyopathy	0.00359	0.00443	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00351	0.00434	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.00337	0.00417	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00333	0.00412	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—RAF1—dilated cardiomyopathy	0.00328	0.00405	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00325	0.00401	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.00321	0.00397	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00304	0.00376	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—RAF1—dilated cardiomyopathy	0.00286	0.00353	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00285	0.00352	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00276	0.00341	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00268	0.00331	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TAZ—dilated cardiomyopathy	0.0026	0.00321	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00258	0.00319	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00258	0.00319	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00247	0.00306	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ANKRD1—dilated cardiomyopathy	0.00246	0.00304	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.0024	0.00297	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SDHA—dilated cardiomyopathy	0.00235	0.0029	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00235	0.0029	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00235	0.0029	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00233	0.00287	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TAZ—dilated cardiomyopathy	0.00232	0.00286	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00226	0.00279	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00218	0.00269	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00211	0.00261	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SDHA—dilated cardiomyopathy	0.00209	0.00259	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00209	0.00258	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00199	0.00245	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—EGFR—dilated cardiomyopathy	0.00196	0.00242	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00188	0.00233	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.0018	0.00223	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.00175	0.00216	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00171	0.00211	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00156	0.00193	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00146	0.00181	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00143	0.00177	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.0014	0.00173	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.0014	0.00172	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00139	0.00171	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00139	0.00171	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00133	0.00164	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00133	0.00164	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00129	0.00159	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00128	0.00158	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00127	0.00157	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00127	0.00157	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00126	0.00155	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00125	0.00154	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00124	0.00154	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TAZ—dilated cardiomyopathy	0.00119	0.00147	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00118	0.00146	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00118	0.00146	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00112	0.00138	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.0011	0.00135	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SDHA—dilated cardiomyopathy	0.00108	0.00133	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00107	0.00132	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00106	0.00131	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00101	0.00125	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000906	0.00112	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000881	0.00109	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000869	0.00107	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00086	0.00106	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	0.000794	0.000981	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000785	0.00097	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AGT—dilated cardiomyopathy	0.00075	0.000927	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000739	0.000913	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000667	0.000825	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000658	0.000813	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000641	0.000792	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GPX1—dilated cardiomyopathy	0.000638	0.000789	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AGT—dilated cardiomyopathy	0.000638	0.000788	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CD36—dilated cardiomyopathy	0.000622	0.000768	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000604	0.000746	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000577	0.000713	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GPX1—dilated cardiomyopathy	0.000569	0.000703	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AGT—dilated cardiomyopathy	0.00056	0.000692	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CD36—dilated cardiomyopathy	0.000554	0.000685	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00052	0.000643	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AGT—dilated cardiomyopathy	0.000499	0.000616	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000442	0.000547	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000357	0.000441	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000303	0.000375	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPX1—dilated cardiomyopathy	0.000293	0.000362	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CD36—dilated cardiomyopathy	0.000285	0.000353	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AGT—dilated cardiomyopathy	0.000257	0.000318	CbGpPWpGaD
